ArticleArteriosclerosis, thrombosis, and vascular biology2018

PAR4 (Protease-Activated Receptor 4): PARticularly Important 4 Antiplatelet Therapy.

Xu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.